• Conference Proceeding

The Impact of Patient Access Pathways on Post Marketing Drug Safety Studies Using Cancer Registry Data

Citation

Midkiff, K., Gilsenan, A., Martin, R. D., Wu, Y., Masica, D. N., & Andrews, E. B. (2009). The Impact of Patient Access Pathways on Post Marketing Drug Safety Studies Using Cancer Registry Data. In [18], pp. S169–S169. .

Abstract